AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15985509 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture at a non‐acupoint 2 cm lateral to Quchi (LI11) thrice weekly for 1 month
Number of subjects: 40
Study 15270401 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 10
Study 15270401 — intervention group
Group type: COMPARATOR
Intervention: US
Number of subjects: 10
Study 11331120 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported weight
Number of subjects: 97
Study 11331120 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported height
Number of subjects: 97
Study 11331120 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported BMI
Number of subjects: 97
Study 11331120 — intervention group
Group type: EXPERIMENTAL
Intervention: Employment status
Number of subjects: 97
Study 11331120 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported eligibility
Number of subjects: 97
Study 9154882 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid (oral administration)
Number of subjects: 60
Study 9154882 — intervention group
Group type: EXPERIMENTAL
Intervention: NAT2 allele composition
Number of subjects: 60
Study 7955261 — intervention group
Group type: EXPERIMENTAL
Intervention: Normothermic CPB (warm, > 34 degrees C)
Number of subjects: 201
Study 7955261 — intervention group
Group type: COMPARATOR
Intervention: Hypothermic CPB (cold, ≤ 28 degrees C)
Number of subjects: 201
Study 3297445 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium infusion
Number of subjects: 130
Study 3297445 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 130
Study 30823886 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditional cash transfer for ANC health visits, facility birth, and postnatal care (PNC) visits until the newborn reaches 1 year of age.
Number of subjects: 7200
Study 28489142 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive cooperation group (20 sessions of 1.5 hours each)
Number of subjects: 293
Study 28489142 — intervention group
Group type: COMPARATOR
Intervention: Routine medical care (control group)
Number of subjects: 293
Study 25435134 — intervention group
Group type: EXPERIMENTAL
Intervention: RRCB
Number of subjects: 50
Study 24120430 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness Based Stress Reduction (MBSR)
Number of subjects: 14
Study 24120430 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 14
Study 21690572 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinorelbine or paclitaxel-containing chemotherapy
Number of subjects: 443
Study 18646333 — intervention group
Group type: EXPERIMENTAL
Intervention: STEP (School‐based Teenage Education Program focusing on HIV Prevention)
Number of subjects: 1846
Study 16682679 — intervention group
Group type: EXPERIMENTAL
Intervention: Rasagiline
Number of subjects: 0
Study 12756055 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Antenatal Care (ANC) protocol
Number of subjects: 164
Study 12756055 — intervention group
Group type: COMPARATOR
Intervention: Traditional ANC protocol
Number of subjects: 164
Study 11090595 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.0 g fish oil daily for 6 weeks
Number of subjects: 20
Study 11090595 — intervention group
Group type: COMPARATOR
Intervention: No supplementation
Number of subjects: 20
Study 9099186 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-related training program involving practice of reaching beyond arm's length.
Number of subjects: 20
Study 9099186 — intervention group
Group type: COMPARATOR
Intervention: Sham training involving cognitive-manipulative tasks within arm's length.
Number of subjects: 20
Study 9099186 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-related training program.
Number of subjects: 20
Study 9099186 — intervention group
Group type: COMPARATOR
Intervention: Control group (sham training).
Number of subjects: 20
Study 1372028 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute treatment with retinoic acid (4 days)
Number of subjects: 29
Study 1372028 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic treatment with retinoic acid (16 weeks)
Number of subjects: 29
Study 3888046 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic androgen fluoxymesterone for 3 days before and on the day of chemotherapy
Number of subjects: 41
Study 3888046 — intervention group
Group type: COMPARATOR
Intervention: Aminoglutethimide and hydrocortisone plus cyclic chemotherapy
Number of subjects: 41
Study 31562291 — intervention group
Group type: EXPERIMENTAL
Intervention: Households with reported domestic accidents (10.2%)
Number of subjects: 578
Study 31562291 — intervention group
Group type: EXPERIMENTAL
Intervention: Households with overcrowding
Number of subjects: 578
Study 31562291 — intervention group
Group type: EXPERIMENTAL
Intervention: Households with safety practices
Number of subjects: 578
Study 31813295 — intervention group
Group type: EXPERIMENTAL
Intervention: CT/MR‐CEUS Fusion Imaging
Number of subjects: 374
Study 31813295 — intervention group
Group type: EXPERIMENTAL
Intervention: 3DUS‐CEUS Fusion Imaging
Number of subjects: 374
Study 31813295 — intervention group
Group type: EXPERIMENTAL
Intervention: CEUS
Number of subjects: 374
Study 27816730 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-Assisted Navigation System (CANS)
Number of subjects: 103
Study 27816730 — intervention group
Group type: COMPARATOR
Intervention: Control (no CANS)
Number of subjects: 103
Study 26078250 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype AG (minor allele)
Number of subjects: 240
Study 26078250 — intervention group
Group type: EXPERIMENTAL
Intervention: FADS2 index (DHA:EPA ratio)
Number of subjects: 240
Study 26078250 — intervention group
Group type: COMPARATOR
Intervention: Genotype GG and AG (both breastfed)
Number of subjects: 240
Study 23278841 — intervention group
Group type: EXPERIMENTAL
Intervention: BFRT LV
Number of subjects: 0
Study 23278841 — intervention group
Group type: EXPERIMENTAL
Intervention: BFRT HV
Number of subjects: 0
Study 23278841 — intervention group
Group type: EXPERIMENTAL
Intervention: HIT
Number of subjects: 0
Study 23278841 — intervention group
Group type: COMPARATOR
Intervention: CON
Number of subjects: 0
Study 23278841 — intervention group
Group type: EXPERIMENTAL
Intervention: All training groups (BFRT LV, BFRT HV, HIT)
Number of subjects: 0
Study 21859314 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone application followed by acid etching
Number of subjects: 40
Study 21859314 — intervention group
Group type: EXPERIMENTAL
Intervention: Acid etching followed by ozone application
Number of subjects: 40
Study 21859314 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone and application of sodium ascorbate
Number of subjects: 40
Study 21859314 — intervention group
Group type: COMPARATOR
Intervention: Not treated with ozone (Control Group 1)
Number of subjects: 40
Study 19107582 — intervention group
Group type: COMPARATOR
Intervention: Placebo response
Number of subjects: 0
Study 19107582 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurobiology of rehearsing or visualizing wellness
Number of subjects: 0
Study 17429350 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaporization using the Volcano device
Number of subjects: 18
Study 17429350 — intervention group
Group type: COMPARATOR
Intervention: Smoking marijuana in a standard cigarette
Number of subjects: 18
Study 14732657 — intervention group
Group type: EXPERIMENTAL
Intervention: delta‐aminolevulinic acid (delta‐ALA) followed by exposure to 10 J/cm(2) of blue light
Number of subjects: 18
Study 14732657 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% urea cream applied to half of the treatment area
Number of subjects: 18
Study 14732657 — intervention group
Group type: EXPERIMENTAL
Intervention: topical 3% lidocaine hydrochloride applied 45 minutes before treatment
Number of subjects: 18
Study 14732657 — intervention group
Group type: COMPARATOR
Intervention: vehicle cream applied to half of the treatment area
Number of subjects: 18
Study 14732657 — intervention group
Group type: COMPARATOR
Intervention: vehicle cream applied 45 minutes before treatment
Number of subjects: 18
Study 12003483 — intervention group
Group type: EXPERIMENTAL
Intervention: CrossAction manual toothbrush
Number of subjects: 113
Study 12003483 — intervention group
Group type: COMPARATOR
Intervention: Actibrush battery-operated power toothbrush
Number of subjects: 113
Study 9563529 — intervention group
Group type: EXPERIMENTAL
Intervention: Early laparoscopic cholecystectomy within 72 hours of admission
Number of subjects: 99
Study 9563529 — intervention group
Group type: COMPARATOR
Intervention: Delayed laparoscopic cholecystectomy after initial medical treatment
Number of subjects: 99
Study 7931478 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 x CMF + TAM
Number of subjects: 473
Study 7931478 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 x CMF
Number of subjects: 473
Study 7931478 — intervention group
Group type: COMPARATOR
Intervention: 3 x CMF
Number of subjects: 473
Study 7931478 — intervention group
Group type: EXPERIMENTAL
Intervention: TAM
Number of subjects: 473
Study 3068038 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphotericin B infusion at a rapid rate (45 minutes)
Number of subjects: 17
Study 3068038 — intervention group
Group type: COMPARATOR
Intervention: Amphotericin B infusion at a slow rate (2 hours)
Number of subjects: 17
Study 31036107 — intervention group
Group type: EXPERIMENTAL
Intervention: Flap fixation technique
Number of subjects: 70
Study 31036107 — intervention group
Group type: COMPARATOR
Intervention: Non-flap fixation (control group)
Number of subjects: 70
Study 29023613 — intervention group
Group type: EXPERIMENTAL
Intervention: rhPDGF-BB-coated equine-derived bone matrix
Number of subjects: 32
Study 29023613 — intervention group
Group type: COMPARATOR
Intervention: rhPDGF-BB-coated β-TCP
Number of subjects: 32
Study 29023613 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 32
Study 25802354 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimecrolimus 1% cream (PIM)
Number of subjects: 2418
Study 25802354 — intervention group
Group type: COMPARATOR
Intervention: Topical corticosteroids (TCSs)
Number of subjects: 2418
Study 23415344 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term educational intervention (24 units) in human biology based on Evidence-based Medicine (EbM) and Good Scientific Practice (GSP)
Number of subjects: 0
Study 23415344 — intervention group
Group type: COMPARATOR
Intervention: Short-term intervention in human biology without EbM and GSP
Number of subjects: 0
Study 21857315 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-hour supervised gym class three times a week plus monthly nutritional counseling
Number of subjects: 0
Study 21857315 — intervention group
Group type: COMPARATOR
Intervention: Monthly workshops to discuss the importance of physical activity and receive nutritional counseling
Number of subjects: 0
Study 19799472 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinfrontal
Number of subjects: 113
Study 16107866 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram 20 mg oral daily
Number of subjects: 58
Study 16107866 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 14871283 — intervention group
Group type: EXPERIMENTAL
Intervention: Balsalazide (750 mg capsules, two capsules twice daily, increased by 750 mg increments to a maximum of 6 g for up to 7 days)
Number of subjects: 128
Study 14673962 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral/pharmacologic group (CB-PHARM)
Number of subjects: 54
Study 14673962 — intervention group
Group type: COMPARATOR
Intervention: Attention-control/pharmacologic group
Number of subjects: 54
Study 14673962 — intervention group
Group type: COMPARATOR
Intervention: Pharmacologic control group
Number of subjects: 54
Study 14673962 — intervention group
Group type: COMPARATOR
Intervention: Aggregated pharmacologic group
Number of subjects: 54
Study 14673962 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 54
Study 10096243 — intervention group
Group type: EXPERIMENTAL
Intervention: FAC/FEC (5-fluorouracil, doxorubicin or epirubicin and cyclophosphamide)
Number of subjects: 60
Study 10096243 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin or epirubicin alone
Number of subjects: 60
Study 10096243 — intervention group
Group type: EXPERIMENTAL
Intervention: FAC/FEC treatment
Number of subjects: 60
Study 7730008 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing model implementation
Number of subjects: 0
Study 7730008 — intervention group
Group type: COMPARATOR
Intervention: Control ward
Number of subjects: 0
Study 2353184 — intervention group
Group type: EXPERIMENTAL
Intervention: Membrane oxygenator
Number of subjects: 96
Study 2353184 — intervention group
Group type: COMPARATOR
Intervention: Bubble oxygenator
Number of subjects: 96
Study 582796 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 14
Study 582796 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 14
Study 582796 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol + Caffeine
Number of subjects: 14
Study 582796 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 30829429 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 1 µg kg‐1 h‐1
Number of subjects: 24
Study 30829429 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine 0.5 µg kg‐1 h‐1
Number of subjects: 24
Study 25794307 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep dry needling (DDN) on 1 active and 1 latent myofascial trigger point (MTrP) of the infraspinatus muscle
Number of subjects: 20
Study 25794307 — intervention group
Group type: COMPARATOR
Intervention: Deep dry needling (DDN) on only 1 active MTrP
Number of subjects: 20
Study 27139255 — intervention group
Group type: EXPERIMENTAL
Intervention: Day-time orthosis (DO)
Number of subjects: 20
Study 27139255 — intervention group
Group type: COMPARATOR
Intervention: Night-time orthosis (NiO)
Number of subjects: 20
Study 27139255 — intervention group
Group type: COMPARATOR
Intervention: No orthosis (NoO)
Number of subjects: 20
Study 24210889 — intervention group
Group type: EXPERIMENTAL
Intervention: AHA 2010 guidelines
Number of subjects: 86
Study 24210889 — intervention group
Group type: COMPARATOR
Intervention: AHA 2005 guidelines
Number of subjects: 86
Study 24210889 — intervention group
Group type: EXPERIMENTAL
Intervention: AHA 2010 guidelines (females)
Number of subjects: 86
Study 22129516 — intervention group
Group type: EXPERIMENTAL
Intervention: dSBP/dHR index (autonomic nervous system regulation index)
Number of subjects: 577
Study 19409342 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐ligating bracket system (SmartClip, 3M Unitek)
Number of subjects: 66
Study 19409342 — intervention group
Group type: COMPARATOR
Intervention: Conventional preadjusted edgewise twin bracket (Victory, 3M Unitek)
Number of subjects: 66
Study 19409342 — intervention group
Group type: EXPERIMENTAL
Intervention: Both bracket systems
Number of subjects: 66
Study 17672173 — intervention group
Group type: EXPERIMENTAL
Intervention: RRMT-3 (3 days per week)
Number of subjects: 20
Study 17672173 — intervention group
Group type: EXPERIMENTAL
Intervention: RRMT-5 (5 days per week)
Number of subjects: 20
Study 17672173 — intervention group
Group type: EXPERIMENTAL
Intervention: RRMT-M (2 days per week)
Number of subjects: 20
Study 15601894 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.0-T diffusion-weighted MR imaging
Number of subjects: 25
Study 15601894 — intervention group
Group type: COMPARATOR
Intervention: 1.5-T diffusion-weighted MR imaging
Number of subjects: 25
Study 12521277 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D (300,000 units, intramuscularly)
Number of subjects: 42
Study 12521277 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium lactate (3 g daily)
Number of subjects: 42
Study 12521277 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of vitamin D and calcium
Number of subjects: 42
Study 12521277 — intervention group
Group type: COMPARATOR
Intervention: Calcium alone
Number of subjects: 42
Study 9806564 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose regimen
Number of subjects: 37
Study 9806564 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose step-up regimen
Number of subjects: 37
Study 9806564 — intervention group
Group type: COMPARATOR
Intervention: Step-down regimen
Number of subjects: 37
Study 8929938 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated comprehensive residential services
Number of subjects: 0
Study 8929938 — intervention group
Group type: EXPERIMENTAL
Intervention: On-site shelter-based intensive case management
Number of subjects: 0
Study 8929938 — intervention group
Group type: COMPARATOR
Intervention: Usual care shelter services with case management
Number of subjects: 0
Study 29579499 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative intervention
Number of subjects: 19
Study 29579499 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 19
Study 27020850 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention during recovery period
Number of subjects: 143
Study 27020850 — intervention group
Group type: COMPARATOR
Intervention: Neutral control stimulus during recovery period
Number of subjects: 143
Study 27020850 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute stress (CO2 stress test)
Number of subjects: 143
Study 25127878 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong intervention (2-hour group training twice a week for 6 weeks, 1-hour follow-up group session once a week for 4 months, 30-minute self-practice daily for 5.5 months)
Number of subjects: 240
Study 25127878 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group (received qigong training after the intervention group)
Number of subjects: 240
Study 24321402 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-conception treatment including dental scaling and root planning, supragingival prophylaxis, and oral hygiene education
Number of subjects: 470
Study 24321402 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving supragingival prophylaxis and oral hygiene education
Number of subjects: 470
Study 20599049 — intervention group
Group type: EXPERIMENTAL
Intervention: Neodymium magnets delivering 15 mTesla (mT)
Number of subjects: 60
Study 20599049 — intervention group
Group type: EXPERIMENTAL
Intervention: Neodymium magnets delivering 45 mTesla (mT)
Number of subjects: 60
Study 20599049 — intervention group
Group type: COMPARATOR
Intervention: Nonmagnetic disk (sham control)
Number of subjects: 60
Study 18464278 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (5 mg/kg/day)
Number of subjects: 21
Study 18464278 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 16943400 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg celecoxib twice daily
Number of subjects: 2005
Study 16943400 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg celecoxib twice daily
Number of subjects: 2005
Study 16943400 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2005
Study 12867305 — intervention group
Group type: EXPERIMENTAL
Intervention: Biphasic truncated exponential (BTE) shocks of 200 J
Number of subjects: 120
Study 12867305 — intervention group
Group type: COMPARATOR
Intervention: Monophasic damped sine (MDS) shocks of 200 J
Number of subjects: 120
Study 12867305 — intervention group
Group type: EXPERIMENTAL
Intervention: Biphasic truncated exponential (BTE) shocks
Number of subjects: 120
Study 12867305 — intervention group
Group type: EXPERIMENTAL
Intervention: Termination of VF at 5 s
Number of subjects: 120
Study 12867305 — intervention group
Group type: EXPERIMENTAL
Intervention: Survival to hospital discharge
Number of subjects: 120
Study 11111146 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated thrombolysis with rt‐PA
Number of subjects: 59
Study 11111146 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 8959426 — intervention group
Group type: EXPERIMENTAL
Intervention: Seven-session structured-group habit reversal treatment
Number of subjects: 16
Study 8959426 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (no treatment)
Number of subjects: 16
Study 1389195 — intervention group
Group type: EXPERIMENTAL
Intervention: Blind oral intubation without the use of a laryngoscope (Group 2)
Number of subjects: 100
Study 1389195 — intervention group
Group type: COMPARATOR
Intervention: Direct laryngoscopy using a Macintosh #3 blade (Group 1)
Number of subjects: 100
Study 3886274 — intervention group
Group type: EXPERIMENTAL
Intervention: Group I (treatment)
Number of subjects: 629
Study 3886274 — intervention group
Group type: EXPERIMENTAL
Intervention: Group II (treatment)
Number of subjects: 629
Study 29331538 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderately high-protein (MHP) diet
Number of subjects: 107
Study 29331538 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat (LF) diet
Number of subjects: 107
Study 28566534 — intervention group
Group type: EXPERIMENTAL
Intervention: PPEP-Pituitary
Number of subjects: 174
Study 26259838 — intervention group
Group type: EXPERIMENTAL
Intervention: DAS28 REM
Number of subjects: 610
Study 26259838 — intervention group
Group type: EXPERIMENTAL
Intervention: SDAI REM
Number of subjects: 610
Study 26259838 — intervention group
Group type: EXPERIMENTAL
Intervention: SDAI LDA
Number of subjects: 610
Study 23461433 — intervention group
Group type: EXPERIMENTAL
Intervention: U-CARE programme
Number of subjects: 53
Study 21936907 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive red cell transfusion strategy (target hemoglobin of 70‐90 g/L)
Number of subjects: 100
Study 21936907 — intervention group
Group type: COMPARATOR
Intervention: Liberal red cell transfusion strategy (target hemoglobin of 90‐110 g/L)
Number of subjects: 100
Study 18201643 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider cueing (using summary 'cueing sheets')
Number of subjects: 286
Study 18201643 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cueing)
Number of subjects: 286
Study 16357546 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided injection
Number of subjects: 40
Study 16357546 — intervention group
Group type: COMPARATOR
Intervention: Blind injection
Number of subjects: 40
Study 12499051 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) concentration of 8-hydroxyguanosine (8-OHG) in PD patients
Number of subjects: 0
Study 12499051 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) concentration of 8-hydroxyguanosine (8-OHG) with duration of disease
Number of subjects: 0
Study 12499051 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum concentration of 8-hydroxyguanosine (8-OHG) in PD patients
Number of subjects: 0